Interventional Study on DEterminants and Factors of Physical ACtivity After Treatments in Oncology
DEFACTO2
1 other identifier
interventional
150
1 country
1
Brief Summary
Benefits of physical activity (PA) as supportive care in cancer have been widely demonstrated by the scientific community. However, survivors who have completed chemo-radio-immunotherapy treatments doesn't achieve PA recommendations on average. This reinforces the need to identify factors influencing PA level, and to propose a multilevel model (macro-, meso-, micro-level) to understand better what facilitates the adoption and maintenance of active behaviour and what hinders it. To date, there is no ecological model in France explaining this behaviour in the post-treatment phase of breast, colorectal, prostate, and lung cancers. From this initial model, we seek to design an educational and motivational intervention in PA. Thus, the investigators propose to test the feasibility of implementing an individualized program to increase and maintain level of physical activity and to decrease sedentary behaviours in physically inactive cancer survivors. This program is based through and identification of barriers and facilitators of an active lifestyle among this population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable breast-cancer
Started Mar 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 29, 2022
CompletedFirst Submitted
Initial submission to the registry
April 11, 2022
CompletedFirst Posted
Study publicly available on registry
May 2, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2023
CompletedMay 9, 2023
May 1, 2023
1.3 years
April 11, 2022
May 8, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Change of physical activity (connected device)
Average daily steps, distance traveled, floors climbed, heart rate, cumulative duration of activities of moderate and vigorous intensities using VIVOSMART4® (Garmin)
One week before initiation of DEFACTO intervention, during the intervention and intervention at Month 3 and Month 6 and Month 12
Secondary Outcomes (7)
Change of physical activity by the Global Physical Activity Questionnaire (GPAQ)
At baseline (at inclusion), and at the completion of intervention (12 weekends after the start of the intervention)
Assessment of life quality
At Baseline (at inclusion), and at the completion of intervention (12 weekends after the start of the intervention)
Assessment of Health literacy level
At Baseline (at inclusion), and at the completion of intervention (12 weekends after the start of the intervention)
Assessment of Knowledge about PA and its link with cancer
At Baseline (at inclusion), and at the completion of intervention (12 weekends after the start of the intervention)
Physical activity barriers
At Baseline (at inclusion), and at the completion of intervention (12 weekends after the start of the intervention)
- +2 more secondary outcomes
Other Outcomes (9)
Weight
At Baseline (at inclusion)
Height
At Baseline (at inclusion)
Date of cancer diagnosis
At Baseline (at inclusion)
- +6 more other outcomes
Study Arms (1)
Intervention
EXPERIMENTALFeasibility group. Single group (intervention group) will be given access to the DEFACTO intervention for twelve-weeks.
Interventions
The single group will access to the twelve-week DEFACTO program containing one adapted physical activity session, two discussion group sessions and several motivational interviewing
Eligibility Criteria
You may qualify if:
- years ≤ age \< 75 years
- survivors of primary non-metastatic breast, lung, prostate or colorectal cancer (stage I, II or III and primary, second and relapse included)
- weeks to 20 years post-treatment (surgery, chemotherapy, radiation therapy and/or immunotherapy) not including hormonal therapy
- Whose ability to participate in the APA intervention has been certified by a medical certificate issued by physician
- Availability and willingness to invest in the DEFACTO study during the program (3 months) and during the post-program follow-up (12 months)
- Participating, on average, in no more than 150 minutes of moderate physical activity or no more than 75 minutes of vigorous activity per week
- Average at least 6 hours a day of sedentary behaviours
- Able to read, understand and complete questionnaires in French
- Able to use connected device (Vivosmart4®) and to perform simple operating actions (press a button, recharge the battery)
- possessing a smartphone which can download Garmin Connect application ®
- Able to walk unassisted
- French speaking and living in France
- having signed the consent form
You may not qualify if:
- Current evidence of metastatic disease
- Having an absolute contraindication by a physician to practice PA
- Using treatments that influence blood pressure, cardiotoxic drugs, painkillers (morphinics);
- Using cane or walking aid
- Deprived of liberty by judicial or administrative decision
- Person under guardianship or curatorship
- Pregnancy and/or lactating women
- Being diagnosed of any cardiac abnormalities
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Université Sorbonne Paris Nordlead
- Ligue contre le cancer, Francecollaborator
- Garmin Internationalcollaborator
- Stimulabcollaborator
Study Sites (1)
Laboratoire Educations et Promotion de la Santé UR3412
Bobigny, 93017, France
Related Publications (1)
Aumaitre A, Gagnayre R, Foucaut AM. Determinants and Factors of Physical Activity After Oncology Treatments (DEFACTO) in Metropolitan France: Protocol of a Mixed Methods Study and Intervention. JMIR Res Protoc. 2024 May 16;13:e52274. doi: 10.2196/52274.
PMID: 38753415DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Aude-Marie AF Foucaut
Université Sorbonne Paris Nord, Laboratoire Educations et Promotion de la Santé UR3412
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
April 11, 2022
First Posted
May 2, 2022
Study Start
March 29, 2022
Primary Completion
July 1, 2023
Study Completion
December 1, 2023
Last Updated
May 9, 2023
Record last verified: 2023-05